Real-time TMF oversight and collaboration with CROs
Single source of truth for eTMF
Digital inspection

As a sponsor, bringing your eTMF in-house and having your CROs work directly in your eTMF can provide long-term benefits, including more control over your data, better oversight, and continual digital inspection readiness in line with the latest EMA expectations.

Hear GW Pharmaceuticals’ experiences on the below topics:
  • The value of an in-house eTMF for better access, real-time control, and inspection readiness
  • How to avoid costly and high-risk end-of-study migrations and ensure compliance with GCP guidelines for digital inspections
  • CRO training and user access management
  • Rapid, cost-effective deployment options

More Customer Stories

Ora: Accelerating Trial Execution
How They Unified Processes
Achieving a Next-Generation Clinical Environment
Learn From Others
GBT's Journey to Strategic TMF Management
Explore the Benefits

Interested in learning more about Veeva?